Brii Biosciences (HKG:2137) resolved to buy back up to HK$60 million of shares in the open market, a Friday bourse filing said.
Chairman Zhi Hong earlier obtained approval from the board to purchase up to 2 million shares in the biopharmaceutical company.
To date, Hong has acquired 499,500 shares and holds a total of 41,297,815, or 5.65% shares in the firm's issued share capital.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。